Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Cutaneous leishmaniasis (CL) is a self-curing skin infection distributed in tropics and sub-tropics. Up to one million cases of CL appeared in endemic areas a year. Leishmanization (artificially controlled infections) was widely used to control cutaneous leishmaniasis in the past. Basal cell carcinoma (BCC) is the most common epithelial neoplasm of the skin. Cases of BCC developing in a leishmanial scar have been documented. We present the first case of confirmed basal cell carcinoma arising in 2020 in an 81-old physician working in Moscow (Russian Federation) in a leishmanial scar. It was 50 years after the primary lesion due to a successful leishmanization, widely used to control cutaneous leishmaniasis in the past.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375728 | PMC |
http://dx.doi.org/10.18502/ijpa.v17i1.9031 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!